Village Green Daily Brief – May 21, 2026


Village Green Daily Brief

Cannabis Industry Intelligence

Curated from social media posts and threads

Published: Wednesday, May 21, 2026 | 7:00 AM ET | Curated by Sheeba

πŸ”₯ FDA Grants Breakthrough Status to Cannabis Pain Drug

The FDA granted Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic pain. Phase 3 trials show it outperformed opioids on pain reduction with no dependence. European approval expected within weeks; US NDA planned for 2028.

Business of Cannabis β†’

βš–οΈ Delaware Court Precedent: Cannabis Company Wins Chapter 15 Bankruptcy

The Cannabist Co. became the first cannabis business to secure US recognition of foreign insolvency proceedings under Chapter 15 of the bankruptcy code. This landmark ruling opens restructuring pathways for cannabis operators previously blocked from US courts.

Restructuring GlobalView β†’

πŸ“‹ RICO Lawsuit Targets Three Major US Cannabis Operators

Class action filed against Cresco Labs, Green Thumb Industries, and Verano Holdings alleges RICO violations and consumer fraudβ€”claiming Big Tobacco tactics. 320-page complaint filed in N. District of Illinois represents 40+ plaintiffs across 12 states. Treble damages exposure high.

Business of Cannabis β†’

🚫 Virginia Governor Vetoes Cannabis Retail Bill

Gov. Spanberger vetoes legislation creating Virginia’s first licensed retail market. Lawmakers rejected her amendments to delay launch and raise taxes. Result: state remains in legal gray area with legal possession but no regulated retail. Special session ongoing.

7News Virginia β†’

πŸ›£οΈ DOT Confirms Drug Testing Rules Unchanged for Transport Workers

Department of Transportation issued guidance that Schedule III reclassification does NOT change federal drug-testing rules for safety-sensitive workers. Policy affects ~6M truck drivers, pilots, train operators. Cannabis use still prohibited in safety roles despite rescheduling.

Business of Cannabis β†’

πŸ’° California Allows 1,600 Operators to Pursue DEA Schedule III Registration

California issued emergency regulations enabling dual-licensed retailers to separate operations for independent Schedule III DEA registration. 60-day expedited window closes late June. Operators must maintain separate products, inventory, and accounts. Public comment May 27-31.

Business of Cannabis β†’

πŸ‡©πŸ‡ͺ Canada Dominates Germany’s Medical Cannabis Market with 53% Import Share

Canadian producers supplied 26,753kg of Germany’s 50,539kg medical cannabis in Q1 2026 (53% share). Q1 total up 34% YoY but down 15% from Q4. EU-GMP certification mandatory; “GMP washing” of non-certified product drawing regulatory scrutiny.

Business of Cannabis β†’

πŸ”¬ UPenn Study: Medical Cannabis Reduces Opioid Use by 65%

Prospective observational study shows patients cut opioid consumption from 46.8 MME/day to 16.2 MME/day within first month using medical cannabis. 7 of 29 participants stopped opioids entirely. Pain scores and physical function improved. Published in Cureus journal.

Business of Cannabis β†’

🏭 Missouri Cannabis Workers Vote to Unionize (11-3)

Sinse cultivation facility workers voted to unionize after NLRB rejected agricultural worker exemption claim. Pre-roll production, data entry, and processing roles deemed non-agricultural. UFCW Local 655 organizing since fall 2023; collective bargaining negotiation starting soon.

Hemp Gazette β†’

⚠️ Federal Hemp Ban Coming November 2026β€”Threatens Medicare Pilot

Hemp ban effective Nov 12 narrows legal hemp to 0.4mg total THC/container, criminalizing most CBD products. Conflicts with new CMS Medicare pilot reimbursing $500/patient for hemp products. Industry seeking 2-year delay or passage of Cannabinoid Safety & Regulation Act.

Business of Cannabis β†’

πŸ“Š Pennsylvania Medical Cannabis Program Hits $9.1B Cumulative Sales

Pennsylvania’s program exceeded $9.1B in total sales since Feb 2018. 438,244 active patient certifications; 1,920 practitioners; 192 dispensaries. Monthly sales consistently exceed $140M. Price compression evident: retail prices fallen from $14.90/g (2021) to $7.60/g (2026).

Business of Cannabis β†’

πŸ›οΈ Minnesota Legislature Approves Cannabis Macrobusiness License Reform

House passes HF4203/SF4401 (92-42 vote) creating new cannabis macrobusiness license effective Jan 1, 2027. Merges medical/adult-use supply chains. Plant canopy limit reduced to 38,000 sq ft. Bridge provision allows hemp businesses to transition into cannabis prior to November hemp ban.

Minnesota House β†’

πŸ“° Village Green Daily Brief β€’ Cannabis Industry Intelligence

Posted to Weedstock.com | Village Green Category


Leave a Reply

📅 Yesterday's News & Older Articles →